Targeting and Dissolution Characteristics of Bone Forming and Antibacterial Drugs by Harnessing the Structure of Microspherical Shells from Coral Beach Sand

被引:21
作者
Chou, Joshua [1 ]
Ben-Nissan, Besim [1 ]
Green, David W. [2 ]
Valenzuela, Stella M. [1 ]
Kohan, Lawrence [1 ]
机构
[1] Univ Technol Sydney, Fac Sci, Broadway, NSW 2007, Australia
[2] Queensland Eye Inst, Brisbane, Qld 4101, Australia
基金
澳大利亚研究理事会;
关键词
DELIVERY; SURFACE;
D O I
10.1002/adem.201000208
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Pharmaceutical drugs for the treatment of metabolic bone diseases lead to a number of side effects due to the their uncontrollable dispersion throughout the body.([1]) Therefore, many groups directed their research to develop devices that are targeted to specific organs or tissues and release the encapsulated drug in a highly regulated way.([2-7]) The development of completely resorbable bone-filling biomaterials delivering drugs would offer a therapeutic approach of drug release and bone augmentation in a simple one-step process.([8-11]) The biomaterials selected needs custom designs, to control the quantity and the duration of drug release and at the same time inducing desirable host cell responses and preventing bacterial infection.([12-15]) Current synthetic biomaterials produced as drug delivery microspheres due to production difficulties contain not very well designed interconnected pores and fail to fill these pertinent requirements. Turning directly to nature such as marine structures for inventive solutions can help to solve these problems due to their structure, chemistry and architecture and their unique designs.([16-20]) We demonstrate -for the first time-the potential of unique coral shells with specific microspherical structure and highly organised interconnected intra-pore designs to offer a number of desired functions for targeted delivery of Bisphosphonate (BP) (paminodrate) and an antibiotic (Gentamicin) for bone regeneration, repair and preventive antibacterial slow drug delivery.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 32 条
[1]   NUCLEAR-MAGNETIC-RESONANCE IDENTIFICATION AND ESTIMATION OF SOLVENT RESIDUES IN COCAINE [J].
AVDOVICH, HW ;
LEBELLE, MJ ;
SAVARD, C ;
WILSON, WL .
FORENSIC SCIENCE INTERNATIONAL, 1991, 49 (02) :225-235
[2]   Effect of 17 beta-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17 beta-estradiol serum kinetics and bone mass in rats [J].
Bauss, F ;
Esswein, A ;
Reiff, K ;
Sponer, G ;
MullerBeckmann, B .
CALCIFIED TISSUE INTERNATIONAL, 1996, 59 (03) :168-173
[3]   Natural bioceramics: from coral to bone and beyond [J].
Ben-Nissan, B .
CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE, 2003, 7 (4-5) :283-288
[4]   EFFECTS OF INTERLEUKIN-1 ON BONE TURNOVER IN NORMAL MICE [J].
BOYCE, BF ;
AUFDEMORTE, TB ;
GARRETT, IR ;
YATES, AJP ;
MUNDY, GR .
ENDOCRINOLOGY, 1989, 125 (03) :1142-1150
[5]  
CAPLAN I, 2006, Patent No. 20060263336
[6]   Bisphosphonate determination using 1H-NMR spectroscopy for biomedical applications [J].
Chou, J. ;
Shimmon, R. ;
Ben-Nissan, B. .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2009, 3 (02) :92-96
[7]  
DEVILLIERS TJ, 2009, BEST PRACTICE RES CL, V23, P336
[8]  
DIEHL WK, 2007, SPECTROSC EUR, V19, P15
[9]   The Next Generation of Drug-Delivery Microdevices [J].
Elman, N. M. ;
Patta, Y. ;
Scott, A. W. ;
Masi, B. ;
Duc, H. L. Ho ;
Cima, M. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) :544-547
[10]   Prostaglandin E2-bisphosphonate conjugates:: Potential agents for treatment of osteoporosis [J].
Gil, L ;
Han, YX ;
Opas, EE ;
Rodan, GA ;
Ruel, R ;
Seedor, JG ;
Tyler, PC ;
Young, RN .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (05) :901-919